Romosozumab is a humanized monoclonal antibody that targets sclerostin, a protein involved in the regulation of bone metabolism. By inhibiting sclerostin, Romosozumab enhances bone formation and decreases bone resorption, making it a valuable tool for investigating the pathophysiology and potential treatments of osteoporosis. This antibody is specifically designed for use in research applications focused on bone density disorders and related metabolic bone diseases.
Romosozumab is a humanized monoclonal antibody that targets sclerostin, a protein involved in the regulation of bone metabolism. By inhibiting sclerostin, Romosozumab enhances bone formation and decreases bone resorption, making it a valuable tool for investigating the pathophysiology and potential treatments of osteoporosis. This antibody is specifically designed for use in research applications focused on bone density disorders and related metabolic bone diseases.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
